Search

Author/Creator Autio, Karen A

1. CD8+ T cell stimulation with pegylated recombinant human IL-10 in the patient with advanced solid tumors - a Phase I study. (4th November 2015)

Authors:
Naing, Aung; Infante, Jeffrey R; Papadopoulos, Kyriakos P; Autio, Karen A; Wong, Deborah J; Falchook, Gerald S; Patel, Manish R; Pant, Shubham; Whiteside, Melinda; Bendell, Johanna; Bauer, Todd M; Janku, Filip; Javle, Milind; Colen, Rivka; Tannir, Nizar; Oft, Martin
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study. Issue 7 (23rd July 2021)

Authors:
Sanborn, Rachel E; Hamid, Omid; de Vries, Elisabeth GE; Ott, Patrick A; Garcia-Corbacho, Javier; Boni, Valentina; Bendell, Johanna; Autio, Karen A; Cho, Daniel C; Plummer, Ruth; Stroh, Mark; Lu, Lawrence; Thistlethwaite, Fiona
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 7(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1). Issue 3 (16th March 2023)

Authors:
Postel-Vinay, Sophie; Lam, Vincent K; Ros, Willeke; Bauer, Todd M; Hansen, Aaron R; Cho, Daniel C; Stephen Hodi, F; Schellens, Jan H M; Litton, Jennifer K; Aspeslagh, Sandrine; Autio, Karen A; Opdam, Frans L; McKean, Meredith; Somaiah, Neeta; Champiat, Stephane; Altan, Mehmet; Spreafico, Anna; Ra...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC). Issue 3 (22nd March 2023)

Authors:
Autio, Karen A; Higano, Celestia S; Nordquist, Luke; Appleman, Leonard J; Zhang, Tian; Zhu, Xin-Hua; Babiker, Hani; Vogelzang, Nicholas J; Prasad, Sandip M; Schweizer, Michael T; Madan, Ravi A; Billotte, Stephane; Cavazos, Nora; Bogg, Orlaith; Li, Ray; Chan, Kam; Cho, Helen; Kaneda, Megan; Wang, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial. Issue 11 (November 2019)

Authors:
Naing, Aung; Wong, Deborah J; Infante, Jeffrey R; Korn, W Michael; Aljumaily, Raid; Papadopoulos, Kyriakos P; Autio, Karen A; Pant, Shubham; Bauer, Todd M; Drakaki, Alexandra; Daver, Naval G; Hung, Annie; Ratti, Navneet; McCauley, Scott; Van Vlasselaer, Peter; Verma, Rakesh; Ferry, David; Oft, Ma...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 11(2019)
Page Start:
1544
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗